Is Sanofi's Dividend Safe?

Sanofi  (NYSE: SNY  ) is one of the globe's largest drug companies. It's a major player in diabetes treatments, vaccines, and consumer medicines, and is often included in dividend portfolios.

However, looming patent expiration on its top-selling drug, falling margin, and potential competition from Eli Lilly (NYSE: LLY  ) and Novo Nordisk (NYSE: NVO  ) could all impact Sanofi's bottom line, and threaten Sanofi's dividend.

In the following slideshow, you'll learn whether I think Sanofi's dividend is safe, and see how Sanofi's dividend matches up to Lilly and Novo Nordisk. 

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 3001256, ~/Articles/ArticleHandler.aspx, 7/25/2014 7:49:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement